ArticleBMC veterinary research2025
Dietary prebiotic-stevioside modulates the growth, antioxidant enzymes, and immune response in thinlip mullets (Liza ramada) subjected to chronic cold stress.
Article in BMC veterinary research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Dietary co-supplementation of silymarin and stevioside enhances growth, immunity, and disease resistance in Nile tilapia.Veterinary research communications · 2026Article
- Coenzyme Q10 and/or stevioside enhance growth, hypoxia tolerance, immune responses, antioxidant capacity, and gene expression profiling in Nile tilapia.Fish physiology and biochemistry · 2026Article
- Comparative socioeconomic, environmental and technical analysis of conventional versus smart sustainable integrated multi-trophic aquaponics systems.Scientific reports · 2025Article
- The Potential Application of PrebioticAquaculture nutrition · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Plant active ingredients, including stevioside, with their prebiotic properties and antioxidant potential, hold promise as innovative components in aquaculture. This study assessed the multi-level impacts of stevioside (0, 100, 200, 300, 400, or 500 mg/kg) on thinlip mullet (N = 540 juveniles with an initial weight 3.50 ± 0.07 g) exposed to a long-term low temperature regime (18 °C) for 60 days. Growth, blood parameters, enzymes, immune genes, and histological structure of intestine and liver were analyzed. Moderate stevioside doses (300-500 mg/kg) significantly boosted growth, with 400 and 500 mg/kg groups showing the highest final and daily weight gain. These doses also increased total protein in blood serum. Interestingly, stevioside did not affect key blood markers like albumin, triglycerides, liver enzymes (ALT and AST), urea, or creatinine. However, it markedly enhanced (P < 0.05) antioxidant enzyme activity in liver (SOD, CAT, GPx) of experimental groups compared to the control group. Gene expression analysis in liver tissue revealed notable effects. Lower stevioside doses (100-300 mg/kg) downregulated genes linked to inflammation (IL-1β) and iron regulation (hepcidin), while higher doses (400-500 mg/kg) showed dose-dependent upregulation (P < 0.05). Histological studies confirmed improved intestinal villi structure and absorptive area in the 300-500 mg/kg groups. This valuable information paves the way for sustainable aquaculture practices utilizing stevioside as a functional ingredient. This study provides key insights into the multi-level responses of juvenile mullets to dietary stevioside, with potential implications for aquatic animals exposed to similar circumstances.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.